Ahn-Gook Pharmaceutical Co. Ltd (001540) — Long-term Investment Intensity
Ahn-Gook Pharmaceutical Co. Ltd (001540) has a Long-term Investment Intensity of 4.2% as of December 2019. Long-term investments of ₩9.07 Billion represent 4.2% of total assets of ₩217.96 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Ahn-Gook Pharmaceutical Co. Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Ahn-Gook Pharmaceutical Co. Ltd Long-term Investment Intensity (2014–2019)
This chart shows how Ahn-Gook Pharmaceutical Co. Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 4.2%, reflecting long-term investments of ₩9.07 Billion against total assets of ₩217.96 Billion KRW. For the complete balance sheet picture, see 001540 total assets.
Annual Long-term Investment Intensity for Ahn-Gook Pharmaceutical Co. Ltd (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for Ahn-Gook Pharmaceutical Co. Ltd from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 001540 total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 4.2% | ₩9.07 Billion | ₩217.96 Billion | ▲ +0.3 pp |
| 2018 | 3.8% | ₩8.17 Billion | ₩212.92 Billion | ▼ -5.3 pp |
| 2017 | 9.2% | ₩19.09 Billion | ₩208.07 Billion | ▲ +0.3 pp |
| 2016 | 8.9% | ₩17.50 Billion | ₩196.27 Billion | ▲ +6.5 pp |
| 2015 | 2.4% | ₩4.74 Billion | ₩197.85 Billion | ▲ +0.0 pp |
| 2014 | 2.4% | ₩4.29 Billion | ₩179.07 Billion | — |